サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1642423

咳止め薬の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日
ページ情報
英文 179 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
咳止め薬の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）
出版日: 2025年01月24日
発行: Fairfield Market Research
ページ情報: 英文 179 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の咳止め薬の市場規模は右肩上がりで、2025年には287億5,000万米ドルに急増し、2032年には443億8,000万米ドルにさらに成長すると予測されています。この拡大には、呼吸器疾患の増加、消費者の意識の高まり、医薬品ソリューションの進歩が寄与しており、CAGRは6.4%です。

咳止め薬（鎮咳薬）は、咳の衝動を最小限に抑えるために処方される医薬品です。これらの医薬品は、脳の咳反射に影響を与えることで作用し、呼吸器感染症、アレルゲン、環境汚染物質によって引き起こされる症状の緩和に役立ちます。同市場では、患者の利便性と治療成績の向上を目指し、新規薬剤の組み合わせや送達メカニズムの強化など、技術革新の波が押し寄せています。

消費者の健康意識の高まりは、一般用医薬品（OTC）咳止め治療薬の需要拡大につながっています。公害、季節性感染症、アレルゲンなど別呼吸器疾患の蔓延が市場の拡大を後押ししています。消費者はしつこい咳に効果的な治療法を積極的に求めており、咳止め製品の売上を伸ばしています。各社は、効能を向上させ副作用を軽減した製剤の開発を優先しています。市場は、複数の有効成分を統合して総合的な緩和を図る配合療法へとシフトしています。液体カプセル、トローチ、スプレーなど、より使いやすい剤形が消費者の人気を集めています。

当レポートでは、世界の咳止め薬市場について調査し、市場の概要とともに、タイプ別、薬剤別、形態別、流通チャネル別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 価格分析、2019年～2023年

第4章 世界の咳止め薬市場の見通し、2019年～2032年

  • 世界の咳止め薬市場の見通し、タイプ別、金額（10億米ドル）、数量（個）、2019年～2032年
  • 世界の咳止め薬市場の見通し、薬剤別、金額（10億米ドル）、数量（個）、2019年～2032年
  • 世界の咳止め薬市場の見通し、形態別、金額（10億米ドル）、数量（個）、2019年～2032年
  • 世界の咳止め薬市場の見通し、流通チャネル別、金額（10億米ドル）、数量（個）、2019年～2032年
  • 世界の咳止め薬市場の見通し、地域別、金額（10億米ドル）、数量（個）、2019年～2032年

第5章 北米の咳止め薬市場の見通し、2019年～2032年

第6章 欧州の咳止め薬市場の見通し、2019年～2032年

第7章 アジア太平洋の咳止め薬市場の見通し、2019年～2032年

第8章 ラテンアメリカの咳止め薬市場の見通し、2019年～2032年

第9章 中東・アフリカの咳止め薬市場の見通し、2019年～2032年

第10章 競合情勢

  • タイプ別vs薬剤別ヒートマップ
  • 企業市場シェア分析、2024年
  • 競争ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • Acella Pharmaceuticals, LLC
    • GlaxoSmithKline Plc
    • Johnson & Johnson services Inc.
    • Merck KGaA
    • Novartis International AG
    • Pfizer Inc.
    • Procter & Gamble

第11章 付録

目次

The global market for cough suppressants is on a steady rise, with projections indicating a surge in value to USD 28.75 billion by 2025 and further growth to USD 44.38 billion by 2032. This expansion is fueled by increasing respiratory ailments, heightened consumer awareness, and advancements in pharmaceutical solutions, driving a compound annual growth rate (CAGR) of 6.4%.

Market Dynamics

Cough suppressants, or antitussives, are pharmaceutical products formulated to minimize the urge to cough. These medications work by influencing the brain's cough reflex, helping alleviate symptoms caused by respiratory infections, allergens, and environmental pollutants. The market is witnessing a wave of innovations, including novel drug combinations and enhanced delivery mechanisms, aimed at improving patient convenience and treatment outcomes.

Growth Drivers

Increasing Health Consciousness & Respiratory Conditions

  • A rise in consumer health awareness is leading to a greater demand for over-the-counter (OTC) cough treatments.
  • The growing prevalence of respiratory illnesses due to pollution, seasonal infections, and allergens is pushing market expansion.
  • Consumers are actively seeking effective remedies for persistent coughs, increasing sales of cough suppressant products.

Innovation & Expansion in Product Offerings

  • Companies are prioritizing R&D to develop enhanced formulations with improved efficacy and reduced side effects.
  • The market is shifting toward combination therapies that integrate multiple active ingredients for comprehensive relief.
  • More user-friendly formats, including liquid capsules, lozenges, and sprays, are gaining popularity among consumers.

Business Opportunities

Development of Pediatric-Specific Products

  • Expanding product lines to include child-friendly formulations with appealing flavors and easy-to-administer formats can address unmet demand.
  • Parents are increasingly searching for safe and effective cough treatments for children, presenting an untapped growth area.

Demand for Natural & Herbal Cough Remedies

  • The increasing preference for natural remedies is encouraging manufacturers to introduce cough suppressants with herbal ingredients such as honey, ginger, and botanical extracts.
  • Brands that cater to the trend of holistic wellness and natural healthcare will have a competitive advantage in the market.

Market Challenges

Regulatory Constraints

  • Stricter regulations on OTC medications pose challenges for market players in terms of compliance and approval.
  • Continuous investment in research and development is necessary to ensure products meet evolving quality and safety standards.

Supply Chain Issues

  • Rising consumer demand, particularly during peak seasons, puts pressure on supply chains.
  • Raw material shortages, logistical barriers, and workforce disruptions create hurdles in maintaining product availability.
  • Companies must adopt resilient supply chain strategies to maintain consistent distribution.

Regional Insights

Europe: Market Leader

  • The region benefits from strong healthcare systems, a high incidence of respiratory conditions, and an aging population with greater susceptibility to cough-related ailments.
  • Strict pharmaceutical regulations ensure high product quality, reinforcing consumer trust and market stability.
  • A growing preference for self-medication and increased awareness of OTC cough remedies contribute to market expansion.

South Asia & Pacific: Fastest-Growing Market

  • Rising awareness about health and increasing respiratory issues drive demand for cough suppressants in this region.
  • Changing environmental conditions and lifestyle factors contribute to a rise in respiratory infections, fueling market growth.
  • A developing healthcare Analysis and a shift toward OTC medication usage make this region an emerging hotspot for market expansion.

Leading Market Players

The cough suppressant market is highly competitive, with key players focusing on innovation and strategic growth. Notable companies in the sector include:

  • Abbott Laboratories
  • Acella Pharmaceuticals, LLC
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • Merck KGaA
  • Novartis International AG
  • Pfizer Inc.
  • Procter & Gamble

Noteworthy Developments

New Product Introductions

  • 2021: Sun Pharmaceutical Industries introduced Chericof 12 in India, featuring an advanced formulation designed to enhance patient recovery from cough symptoms.
  • Market Impact: This innovation highlights the pharmaceutical sector's commitment to addressing evolving healthcare needs with effective cough suppressant solutions.

Strategic Acquisitions

  • 2023: GSK Plc acquired Bellus Health Inc., strengthening its portfolio of treatments for cough and related respiratory conditions.
  • Market Impact: This acquisition reinforces GSK's position in the market, enhancing its ability to provide diverse and effective cough suppressant solutions while expanding its global reach.

Market Segmentation

The cough suppressant market is categorized based on type, active ingredients, form, sales channels, and geography.

By Type:

  • Acute Cough
  • Chronic Cough

By Active Ingredients:

  • Dextromethorphan
  • Codeine
  • Butramirate
  • Benzonatate
  • Others

By Form:

  • Tablets/Capsules
  • Liquid Syrups
  • Sprays

By Sales Channels:

  • Hospitals
  • Retail Pharmacies
  • Drug Stores
  • E-commerce Platforms

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cough Suppressant Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis by Type, 2019 - 2023
  • 3.2. Prominent Factor Affecting Cough Suppressant Prices
  • 3.3. Global Average Price Analysis by Region

4. Global Cough Suppressant Market Outlook, 2019 - 2032

  • 4.1. Global Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Acute Cough
      • 4.1.1.2. Chronic Cough
  • 4.2. Global Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Dextromethorphan
      • 4.2.1.2. Codeine
      • 4.2.1.3. Butramirate
      • 4.2.1.4. Bennzonatate
      • 4.2.1.5. Others
  • 4.3. Global Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Solid
      • 4.3.1.2. Liquid
      • 4.3.1.3. Spray
  • 4.4. Global Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals
      • 4.4.1.2. Retail Pharmacies
      • 4.4.1.3. Drug Stores
      • 4.4.1.4. Online Pharmacies
  • 4.5. Global Cough Suppressant Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. North America
      • 4.5.1.2. Europe
      • 4.5.1.3. Asia Pacific
      • 4.5.1.4. Latin America
      • 4.5.1.5. Middle East & Africa

5. North America Cough Suppressant Market Outlook, 2019 - 2032

  • 5.1. North America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Acute Cough
      • 5.1.1.2. Chronic Cough
  • 5.2. North America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Dextromethorphan
      • 5.2.1.2. Codeine
      • 5.2.1.3. Butramirate
      • 5.2.1.4. Bennzonatate
      • 5.2.1.5. Others
  • 5.3. North America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Solid
      • 5.3.1.2. Liquid
      • 5.3.1.3. Spray
  • 5.4. North America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Retail Pharmacies
      • 5.4.1.3. Drug Stores
      • 5.4.1.4. Online Pharmacies
    • 5.4.2. Attractiveness Analysis
  • 5.5. North America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. U.S. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.2. U.S. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.3. U.S. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.4. U.S. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.5. Canada Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.6. Canada Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.7. Canada Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.8. Canada Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

6. Europe Cough Suppressant Market Outlook, 2019 - 2032

  • 6.1. Europe Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Acute Cough
      • 6.1.1.2. Chronic Cough
  • 6.2. Europe Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Dextromethorphan
      • 6.2.1.2. Codeine
      • 6.2.1.3. Butramirate
      • 6.2.1.4. Bennzonatate
      • 6.2.1.5. Others
  • 6.3. Europe Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Solid
      • 6.3.1.2. Liquid
      • 6.3.1.3. Spray
  • 6.4. Europe Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Retail Pharmacies
      • 6.4.1.3. Drug Stores
      • 6.4.1.4. Online Pharmacies
    • 6.4.2. Attractiveness Analysis
  • 6.5. Europe Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. Germany Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.2. Germany Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.3. Germany Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.4. Germany Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.5. U.K. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.6. U.K. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.7. U.K. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.8. U.K. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.9. France Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.10. France Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.11. France Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.12. France Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.13. Italy Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.14. Italy Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.15. Italy Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.16. Italy Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.17. Turkey Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.18. Turkey Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.19. Turkey Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.20. Turkey Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.21. Russia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.22. Russia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.23. Russia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.24. Russia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.25. Rest of Europe Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.26. Rest of Europe Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.27. Rest of Europe Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.28. Rest of Europe Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

7. Asia Pacific Cough Suppressant Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Acute Cough
      • 7.1.1.2. Chronic Cough
  • 7.2. Asia Pacific Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Dextromethorphan
      • 7.2.1.2. Codeine
      • 7.2.1.3. Butramirate
      • 7.2.1.4. Bennzonatate
      • 7.2.1.5. Others
  • 7.3. Asia Pacific Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Solid
      • 7.3.1.2. Liquid
      • 7.3.1.3. Spray
  • 7.4. Asia Pacific Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Retail Pharmacies
      • 7.4.1.3. Drug Stores
      • 7.4.1.4. Online Pharmacies
    • 7.4.2. Attractiveness Analysis
  • 7.5. Asia Pacific Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. China Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.2. China Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.3. China Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.4. China Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.5. Japan Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.6. Japan Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.7. Japan Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.8. Japan Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.9. South Korea Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.10. South Korea Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.11. South Korea Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.12. South Korea Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.13. India Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.14. India Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.15. India Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.16. India Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.17. Southeast Asia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.18. Southeast Asia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.19. Southeast Asia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.20. Southeast Asia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.21. Rest of Asia Pacific Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.22. Rest of Asia Pacific Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.23. Rest of Asia Pacific Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.24. Rest of Asia Pacific Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

8. Latin America Cough Suppressant Market Outlook, 2019 - 2032

  • 8.1. Latin America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Acute Cough
      • 8.1.1.2. Chronic Cough
  • 8.2. Latin America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Dextromethorphan
      • 8.2.1.2. Codeine
      • 8.2.1.3. Butramirate
      • 8.2.1.4. Bennzonatate
      • 8.2.1.5. Others
  • 8.3. Latin America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Solid
      • 8.3.1.2. Liquid
      • 8.3.1.3. Spray
  • 8.4. Latin America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Retail Pharmacies
      • 8.4.1.3. Drug Stores
      • 8.4.1.4. Online Pharmacies
    • 8.4.2. Attractiveness Analysis
  • 8.5. Latin America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. Brazil Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.2. Brazil Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.3. Brazil Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.4. Brazil Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.5. Mexico Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.6. Mexico Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.7. Mexico Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.8. Mexico Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.9. Argentina Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.10. Argentina Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.11. Argentina Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.12. Argentina Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.13. Rest of Latin America Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.14. Rest of Latin America Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.15. Rest of Latin America Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.16. Rest of Latin America Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

9. Middle East & Africa Cough Suppressant Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Acute Cough
      • 9.1.1.2. Chronic Cough
  • 9.2. Middle East & Africa Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Dextromethorphan
      • 9.2.1.2. Codeine
      • 9.2.1.3. Butramirate
      • 9.2.1.4. Bennzonatate
      • 9.2.1.5. Others
  • 9.3. Middle East & Africa Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Solid
      • 9.3.1.2. Liquid
      • 9.3.1.3. Spray
  • 9.4. Middle East & Africa Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. Hospitals
      • 9.4.1.2. Retail Pharmacies
      • 9.4.1.3. Drug Stores
      • 9.4.1.4. Online Pharmacies
    • 9.4.2. Attractiveness Analysis
  • 9.5. Middle East & Africa Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1. Key Highlights
      • 9.5.1.1. GCC Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.2. GCC Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.3. GCC Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.4. GCC Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.5. South Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.6. South Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.7. South Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.8. South Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.9. Egypt Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.10. Egypt Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.11. Egypt Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.12. Egypt Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.13. Nigeria Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.14. Nigeria Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.15. Nigeria Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.16. Nigeria Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.17. Rest of Middle East & Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.18. Rest of Middle East & Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.19. Rest of Middle East & Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.20. Rest of Middle East & Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

10. Competitive Landscape

  • 10.1. By Type vs by Drugs Heatmap
  • 10.2. Company Market Share Analysis, 2024
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Abbott Laboratories
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Acella Pharmaceuticals, LLC
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. GlaxoSmithKline Plc
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Johnson & Johnson services Inc.
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Merck KGaA
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Novartis International AG
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Pfizer Inc.
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Procter & Gamble
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations